Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Heene

Showing results (91-100 of 147) with videos related to

Pageof 15
Sort By:
Seminars in Thrombosis and Hemostasis|January 1, 1997
Anticoagulation in patients with heparin-induced thrombocytopenia type IIJ Harenberg, G Huhle, L Piazolo, et al.
Thrombosis and Haemostasis|April 30, 1976
Studies on chemically modified fibrinogenM Kloczewiak, Z Wegrzynowicz, F R Matthias, et al.
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1987
Pharmacokinetics of n-propyl-ajmaline-bitartrate in elderly patients with ventricular ectopic activityR Elfner, G Achtert, H J Hausleiter, et al.
Journal of Neurosurgery|March 6, 1999
Direct convective macromolecule deliveryG Stehle, D L Heene, A Wunder, et al.
Blood|April 5, 2001
Increase in platelet count in response to rHuEpo in a patient with thrombocytopenia and absent radii syndromeC E Dempfle, C Burck, T Grützmacher, et al.
Thrombosis and Haemostasis|June 30, 1989
Biological activity and safety of the subcutaneous administration of high doses of low molecular weight heparin for 8 days in human volunteersJ Harenberg, C Giese, C E Dempfle, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1995
Monitoring of heparins in haemodialysis using an anti-factor-Xa-specific whole-blood clotting assayJ Harenberg, B Haaf, C E Dempfle, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1997
Comparison of the pharmacodynamic and pharmacokinetic profiles of two low-molecular-mass heparins in ratsL Piazolo, J Harenberg, R Malsch, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 1, 1996
Effects of low-molecular-weight dermatan sulfate on coagulation, fibrinolysis and tissue factor pathway inhibitor in healthy volunteersJ Harenberg, M Jeschek, M Acker, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1989
The pharmacological profile of the low molecular weight heparin 21-23 in man: anticoagulant, lipolytic and protamine reversible effectsJ Harenberg, G Stehle, C E Dempfle, et al.
Pageof 15

Showing results (91-100 of 147) with videos related to

Sort By:
Pageof 15
Seminars in Thrombosis and Hemostasis|January 1, 1997
Anticoagulation in patients with heparin-induced thrombocytopenia type IIJ Harenberg, G Huhle, L Piazolo, et al.
Thrombosis and Haemostasis|April 30, 1976
Studies on chemically modified fibrinogenM Kloczewiak, Z Wegrzynowicz, F R Matthias, et al.
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1987
Pharmacokinetics of n-propyl-ajmaline-bitartrate in elderly patients with ventricular ectopic activityR Elfner, G Achtert, H J Hausleiter, et al.
Journal of Neurosurgery|March 6, 1999
Direct convective macromolecule deliveryG Stehle, D L Heene, A Wunder, et al.
Blood|April 5, 2001
Increase in platelet count in response to rHuEpo in a patient with thrombocytopenia and absent radii syndromeC E Dempfle, C Burck, T Grützmacher, et al.
Thrombosis and Haemostasis|June 30, 1989
Biological activity and safety of the subcutaneous administration of high doses of low molecular weight heparin for 8 days in human volunteersJ Harenberg, C Giese, C E Dempfle, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1995
Monitoring of heparins in haemodialysis using an anti-factor-Xa-specific whole-blood clotting assayJ Harenberg, B Haaf, C E Dempfle, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1997
Comparison of the pharmacodynamic and pharmacokinetic profiles of two low-molecular-mass heparins in ratsL Piazolo, J Harenberg, R Malsch, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 1, 1996
Effects of low-molecular-weight dermatan sulfate on coagulation, fibrinolysis and tissue factor pathway inhibitor in healthy volunteersJ Harenberg, M Jeschek, M Acker, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1989
The pharmacological profile of the low molecular weight heparin 21-23 in man: anticoagulant, lipolytic and protamine reversible effectsJ Harenberg, G Stehle, C E Dempfle, et al.
Pageof 15